Drugs / NPH
last change Jun 2018 re-read 3 minutes ago

NPH

Protein / enzyme biologic

Developed for
diabetes mellitus
Investigated by
Eli Lilly and Company · Hennepin Healthcare Research Institute

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01970241 Jul 2014 → Jun 2016 diabetes mellitus Hennepin Healthcare Research Institute Completed Met primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as NPH ClinicalTrials.gov intervention name — accepted as the source's own label NCT01970241 ↗
Modality Protein / enzyme biologic “neutral protamine Hagedorn (NPH) insulin-based protocol” PMID 29961246 ↗ Jun 2018